✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Mitomycin is a drug marketed by Accord Hlthcare, Gland Pharma Ltd, Hikma, Hospira, and Rk Pharma. and is included in seven NDAs.
The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mitomycin profile page.
A generic version of MITOMYCIN was approved as mitomycin by HIKMA on April 19th, 1995.
Summary for MITOMYCIN
Recent Clinical Trials for MITOMYCIN
Identify potential brand extensions & 505(b)(2) entrants
|University of Bern||Phase 2|
|Hospital Centre Biel/Bienne||Phase 2|
|University Hospital Inselspital, Berne||Phase 2|
Medical Subject Heading (MeSH) Categories for MITOMYCIN
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Accord Hlthcare||MITOMYCIN||mitomycin||INJECTABLE;INJECTION||064144-001||Apr 30, 1998||AP||RX||No||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Hikma||MITOMYCIN||mitomycin||INJECTABLE;INJECTION||064180-001||Dec 23, 1999||AP||RX||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Gland Pharma Ltd||MITOMYCIN||mitomycin||INJECTABLE;INJECTION||215687-001||Oct 20, 2021||AP||RX||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|